DBMYX
Price
$30.23
Change
+$0.40 (+1.34%)
Updated
Jun 23 closing price
Net Assets
1.04B
PMBPX
Price
$45.09
Change
+$0.54 (+1.21%)
Updated
Jun 23 closing price
Net Assets
30.62B
Interact to see
Advertisement

DBMYX vs PMBPX

Header iconDBMYX vs PMBPX Comparison
Open Charts DBMYX vs PMBPXBanner chart's image
BNY Mellon Sm/Md Cp Gr Y
Price$30.23
Change+$0.40 (+1.34%)
VolumeN/A
Net Assets1.04B
Principal MidCap R5
Price$45.09
Change+$0.54 (+1.21%)
VolumeN/A
Net Assets30.62B
DBMYX vs PMBPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DBMYX vs. PMBPX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMYX is a Buy and PMBPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 30.6B vs. DBMYX (1.04B). PMBPX pays higher dividends than DBMYX: PMBPX (0.01) vs DBMYX (0.00). DBMYX was incepted earlier than PMBPX: DBMYX (12 years) vs PMBPX (25 years). PMBPX (0.83) is less costly to investors than DBMYX (0.67). DBMYX is a more actively managed with annual turnover of: 48.92 vs. PMBPX (10.50). PMBPX has a lower initial minimum investment than DBMYX: PMBPX (0) vs DBMYX (1000000). DBMYX annual gain was more profitable for investors over the last year : 13.47 vs. PMBPX (9.93). PMBPX return over 5 years is better than : 56.99 vs. DBMYX (-2.87).
DBMYXPMBPXDBMYX / PMBPX
Total Expense Ratio0.620.8375%
Annual Report Gross Expense Ratio0.670.8381%
Fund Existence12 years25 years-
Gain YTD2.1582.50886%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B30.6B3%
Annual Yield % from dividends0.000.01-
Returns for 1 year13.479.93136%
Returns for 3 years27.4243.9562%
Returns for 5 years-2.8756.99-5%
Returns for 10 years57.9192.4463%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KNSA28.720.24
+0.84%
Kiniksa Pharmaceuticals International plc
GWRE238.400.65
+0.27%
Guidewire Software
ETON13.51-0.19
-1.39%
Eton Pharmaceuticals
SINT3.07-0.08
-2.54%
SiNtx Technologies Inc.
BCAX9.18-0.25
-2.65%
Bicara Therapeutics Inc.